MED-EL Corporation Company Profile
Since its founders developed one of the worldĂ˘Â€Â™s first cochlear implants in the 1970s, MED-EL has set new standards in hearing implant technologies, developing and manufacturing technologically advanced hearing solutions for people with varying degrees of hearing loss. MED-EL hearing implant systems, currently used in 96 countries, combine the latest scientific advances, engineering and manufacturing techniques for performance, safety and reliability. MED-EL offers the broadest portfolio of hearing implant systems, including the MAESTRO Cochlear Implant system for those with severe-to-profound sensorineural hearing loss and the unique Vibrant SoundbridgeĂ‚Â®, a middle ear prosthesis for the treatment of moderate to severe sensorineural hearing loss. The fast-growing medical technology company employs more than 1,000 people worldwide, more than 650 of whom are based at the companyĂ˘Â€Â™s headquarters in Innsbruck, where R&D and production are located. For more information, visit www.medel.com or call 888-MED-EL-CI (633-3524).
Drugs and Medications
More Information about "MED-EL Corporation" on BioPortfolio
We have published hundreds of MED-EL Corporation news stories on BioPortfolio along with dozens of MED-EL Corporation Clinical Trials and PubMed Articles about MED-EL Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MED-EL Corporation Companies in our database. You can also find out about relevant MED-EL Corporation Drugs and Medications on this site too.